CLO Mitchell Shawnte sells entire 40,000-share stake in OLMA for $951.5K across 3 transactions (Mar 3-4)
Mitchell Shawnte, Chief Legal Officer, liquidated his entire 40,000-share position in Olema Pharmaceuticals through three separate sales on March 3-4, 2026, realizing $951,502.52 at a blended average price of $23.79. The complete exit is notable given that the stock now trades at $22.56, down 37.0% from its 52-week high and down 13.7% over the prior 30 days. Olema is currently unprofitable with net income of $-42,217,000.00 for its most recent full fiscal year, and the company's market cap of $1,548,967,862.88 reflects a biotech firm in burn-down mode. A C-suite legal officer's total divestment removes a meaningful information asymmetry holder from the cap table, particularly at a company facing negative profitability and recent equity price deterioration.